Update: Alnylam Pharmaceuticals Shares Rise as Heart Disease Candidate Meets Primary Endpoint in Late-Stage Study

(Updates to reflect stock price movement in the headline and first paragraph.) Alnylam Pharmaceuticals (ALNY) shares were up more than 6% in recent Tuesday trading, a day after the company said vutris

MT NewswiresJun 26 01:17

10 Health Care Stocks Whale Activity In Today's Session

This whale alert can help traders discover the next big trading opportunities.Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scan

Benzinga01:35

Alnylam Pharmaceuticals on Track for Record High Close -- Data Talk

Alnylam Pharmaceuticals, Inc (ALNY) is currently at $245.68, up $5.53 or 2.3% --Would be new all-time high (Based on available data back to May 28, 2004) --Would be the first record close since Dec.

Dow Jones00:22

A Quick Look at Today's Ratings for Alnylam Pharmaceuticals(ALNY.US), With a Forecast Between $234 to $291

On Jun 26, major Wall Street analysts update their ratings for $Alnylam Pharmaceuticals(ALNY.US)$, with price targets ranging from $234 to $291.Morgan Stanley analyst Michael Ulz maintains with a hold

Futu NewsJun 26 21:00 · Ratings

US stocks dig gold | The two giants of weight-loss drugs have refreshed their heights! Novo Nordisk's weight-loss drug has been approved for sale in China; performance has ignited stock prices! Carnival Cruise Line soared nearly 9% after the results.

Medical global sectors are rebounding! Intuitive Surgical rose more than 3%, up more than 30% this year, with an average annual ROI of 24% over the past 15 years. Alnylam Pharmaceuticals rose nearly 8%, up more than 55% in the past four trading days, and positive phase 3 data for new drugs is still fermenting. Regeneron Pharmaceuticals rose nearly 1%, up more than 20% this year, with RBC Capital Markets analyst maintaining a target price of $1229 per share.

Futu NewsJun 26 18:10

Form 144 | Alnylam Pharmaceuticals(ALNY.US) Director Proposes to Sell 2.04 Million in Common Stocks

SEC FILLINGS DISCLOSED/ Jun 25, $Alnylam Pharmaceuticals(ALNY.US)$ Director SCHULMAN AMY W intends to sell 8,500 shares of its common stock on Jun 25, with a total market value of approximately $2.04

Futu NewsJun 26 04:18